文献速递免疫规划传染病防控与疫情报告

阿根廷实施 universal 轮状病毒疫苗接种规划十年后对儿童腹泻疾病负担影响的综合评估

Comprehensive assessment of the impact of universal rotavirus vaccination program on the burden of diarrheal disease in children after 10 years of implementation in Argentina.
PubMed 文献 · Vaccine · 2025-08-29

阿根廷于2015年将单价轮状病毒疫苗纳入国家免疫规划,采用2月龄和4月龄两剂次接种。本研究通过混合生态学时间趋势分析评估该规划实施十年(含新冠疫情期间)对5岁以下儿童腹泻疾病负担的影响,结果显示急性腹泻率下降59.6%、住院率下降47.6%、死亡率下降59.7%,实验室确诊轮状病毒阳性率下降55.2%,婴儿肠套叠住院率全国下降超过30%,各指标在新冠后仍低于基线水平。

要点

  • 与接种前时期相比,急性腹泻率下降59.6%,腹泻相关住院率下降47.6%,腹泻相关死亡率下降59.7%。
  • 实验室确诊轮状病毒阳性率下降55.2%,一岁以下婴儿降幅最明显。
  • 婴儿肠套叠住院率全国下降超过30%,无地区超过接种前水平;疫苗覆盖率在疫情期间下降且恢复不完全。

核心结论

  • 阿根廷引入universal轮状病毒疫苗接种十年后,多个指标显示腹泻疾病负担大幅且持续下降,疫苗总体获益-风险特征仍强烈有利。
  • 需要持续努力加强疫苗覆盖和监测系统,以巩固这些成果并及时发现潜在的不良趋势。

研究设计与样本

  • 混合生态学时间趋势分析,使用来自监测和卫生信息系统的国家和区域二级数据。
  • 评估六项指标:门诊急性腹泻病例、腹泻住院、腹泻相关死亡、婴儿肠套叠住院、实验室确诊轮状病毒病例和轮状病毒疫苗覆盖率。
  • 比较四个时期:接种前(2010-2014年)、接种后新冠前(2016-2019年)、新冠期间(2020-2021年)和新冠后(2022-2024年)。

主要发现

  • 与接种前时期相比,急性腹泻率下降59.6%,住院率下降47.6%,死亡率下降59.7%。
  • 实验室确诊轮状病毒阳性率下降55.2%,一岁以下婴儿降幅最明显。
  • 新冠后部分指标出现部分反弹,但所有指标仍低于基线水平。
  • 婴儿肠套叠住院率全国下降超过30%,无地区显示超过接种前疫苗水平的率。
  • 疫苗覆盖率在疫情期间下降并显示不完全恢复;统计分析确认大多数指标在年龄组和时期之间存在显著差异,尤其突出婴儿对严重结局的持续脆弱性。

临床怎么用

  • 原文未据此给出推荐。
  • 作者结论指出,持续努力加强疫苗覆盖和监测系统对巩固成果和确保及时发现潜在不良趋势至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In 2015, Argentina introduced the monovalent rotavirus vaccine into its National Immunization Program with a two-dose schedule at 2 and 4 months of age. This study assessed the impact of the universal rotavirus vaccination program on the burden of diarrheal disease in children under five years of age over a ten-year period, including the effects of the COVID-19 pandemic. METHODS: A mixed ecological time-trend analysis was conducted using national and regional secondary data from surveillance and health information systems. Six indicators were evaluated: outpatient acute diarrhea cases, hospitalizations due to diarrhea, diarrhea-related deaths, intussusception hospitalizations in infants, laboratory-confirmed rotavirus cases, and rotavirus vaccine coverage. Trends were compared across four periods: pre-vaccination (2010-2014), post-vaccination pre-COVID-19 (2016-2019), during COVID-19 (2020-2021), and post-COVID-19 (2022-2024). RESULTS: Compared to the pre-vaccination period, acute diarrhea rates declined by 59.6%, hospitalizations by 47.6%, and mortality by 59.7%. Laboratory-confirmed rotavirus positivity fell by 55.2%, with the most pronounced reductions observed in infants under one year of age. Although partial rebounds were noted post-COVID-19, all indicators remained below baseline levels. Intussusception hospitalizations in infants decreased by over 30% nationally, and no region showed rates exceeding pre-vaccine levels. Vaccine coverage declined during the pandemic and showed incomplete recovery. Statistical analyses confirmed significant differences by age group and period for most indicators, particularly highlighting the persistent vulnerability of infants to severe outcomes. CONCLUSIONS: Ten years after the introduction of universal rotavirus vaccination in Argentina, a substantial and sustained reduction in the burden of diarrheal disease was observed across multiple indicators. While regional variability and post-pandemic fluctuations were noted, the overall benefit-risk profile of the vaccine remains strongly favorable. Continued efforts to strengthen vaccine coverage and surveillance systems are essential for consolidating these gains and ensuring timely detection of potential adverse trends.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Degiuseppe JI. Comprehensive assessment of the impact of universal rotavirus vaccination program on the burden of diarrheal disease in children after 10 years of implementation in Argentina. Vaccine. 2025. PMID: 40884908. doi:10.1016/j.vaccine.2025.127681

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。